Hutton DW, Stein JD, Glassman AR. et al. Five-year cost-effectiveness of intravitreous ranibizumab therapy vs. panretinal photocoagulation for treating proliferative diabetic retinopathy: a secondary analysis of a randomized clinical trial. JAMA Ophthalmol 2019; 24: 1-9 doi:10.1001/jamaophthalmol.2019.4284
Download Bibliographical Data
We do not assume any responsibility for the contents of the web pages of other providers.